Use of proline specific endoproteases to hydrolyse peptides and proteins
    31.
    发明申请
    Use of proline specific endoproteases to hydrolyse peptides and proteins 有权
    使用脯氨酸特异性内切蛋白酶水解肽和蛋白质

    公开(公告)号:US20070031399A1

    公开(公告)日:2007-02-08

    申请号:US10572811

    申请日:2004-09-23

    摘要: The present invention relates to a process for the proteolytic hydrolysis of a peptide or a polypeptide, said peptide or polypeptide comprising 4 to 40, preferably 5 to 35, amino acid residues and said peptide or polypeptide is not hydrolysable by subtilisin whereby said peptide or polypeptide is hydrolysed by a proline specific endo protease at a pH of 6.5 or lower, preferably 5.5 or lower and more preferably 5.0 or lower to hydrolyse said peptide or polypeptide.

    摘要翻译: 本发明涉及肽或多肽的蛋白水解水解方法,所述肽或多肽包含4至40个,优选5至35个氨基酸残基,并且所述肽或多肽不能被枯草杆菌蛋白酶水解,因此所述肽或多肽 由pH6.5或更低,优选5.5或更低,更优选5.0或更低的脯氨酸特异性内切蛋白酶水解,以水解所述肽或多肽。

    TESTING EFFICACY FOR CELIAC DISEASE
    36.
    发明申请
    TESTING EFFICACY FOR CELIAC DISEASE 审中-公开
    CELIAC疾病的测试效果

    公开(公告)号:US20120107847A1

    公开(公告)日:2012-05-03

    申请号:US13381865

    申请日:2010-06-24

    摘要: We describe a method to determine effectiveness of a compound or composition in treatment of celiac disease or gluten intolerance, the method comprising: administration of the compound or composition to one or more human patients who were on a gluten-free diet for 10 years or less, preferably 6 years or less; challenge with gluten of the one or more human patients who were administered the compound or composition; and determining whether there is a change in condition of celiac disease or gluten intolerance of the one or more patients that results from administration of the compound or composition and challenge with gluten; whereby no significant change in condition indicates that the compound or composition would be effective in treating celiac disease or gluten intolerance.

    摘要翻译: 我们描述了一种确定化合物或组合物治疗乳糜泻或麸质不耐症的有效性的方法,该方法包括:将化合物或组合物施用于一个或多个无麸质饮食10年以上的人类患者 ,优选6年以下; 对施用化合物或组合物的一个或多个人类患者的面筋进行挑战; 以及确定由所述化合物或组合物的施用引起的一种或多种患者的腹腔疾病或麸质不耐受状况是否发生变化,并用面筋进行攻击; 因此条件没有显着变化表明化合物或组合物将有效治疗乳糜泻或麸质不耐受。

    USES FOR AQUEOUS STREAMS CONTAINING PROTEINS
    39.
    发明申请
    USES FOR AQUEOUS STREAMS CONTAINING PROTEINS 审中-公开
    用于含有蛋白质的水溶液

    公开(公告)号:US20100286034A1

    公开(公告)日:2010-11-11

    申请号:US12811051

    申请日:2008-12-10

    摘要: The present invention relates to a protein hydrolysate comprising free amino acids and peptides whereby the weight ratio of free amino acids to peptides is about 1:1 and wherein at least about 50 molar % of the peptides has a molecular weight of 400 Da or less. This composition may be rich in one or more branched-chain amino acid-(BCAA-) and or glutamine-containing di- or tripeptides. Also, the invention relates to the use of a water soluble protein-containing aqueous fraction obtained from a wet-milling process or the protein hydrolysate in: the manufacture of a medicament for the treatment or prevention of a condition associated with inappropriate blood sugar metabolism; aiding recovery and/or endurance during or after exercise; stimulating the generation of lean body mass; infant nutrition; or the preparation of a food or feed composition or a food or feed supplement.

    摘要翻译: 本发明涉及包含游离氨基酸和肽的蛋白质水解物,其中游离氨基酸与肽的重量比为约1:1,其中至少约50摩尔%的肽具有400Da或更小的分子量。 该组合物可以富含一个或多个支链氨基酸 - (BCAA-)和/或含谷氨酰胺的二肽或三肽。 此外,本发明涉及在湿法研磨或蛋白质水解产物中得到的含水溶性蛋白质的水性组分的用途:制备用于治疗或预防与不适当的血糖代谢有关的病症的药物; 在运动期间或之后协助康复和/或耐力; 刺激瘦体重的产生; 婴幼儿营养; 或制备食物或饲料组合物或食品或饲料补充剂。

    Hydrolyzed milk proteins
    40.
    发明授权
    Hydrolyzed milk proteins 失效
    水解乳蛋白

    公开(公告)号:US07648721B2

    公开(公告)日:2010-01-19

    申请号:US10483948

    申请日:2002-07-18

    IPC分类号: A61K39/00 A61K39/38

    摘要: The present invention provides a composition comprising hydrolysed milk casein and, preferably non-hydrolysed whey protein in a ratio from 9:1 to 1:1 (on dry weight), which is a clear liquid at pH 4 when dissolved or present in water in an amount of 40 g/liter at 10° C.

    摘要翻译: 本发明提供了一种组合物,其包含水解乳酪蛋白和优选非水解乳清蛋白,其比例为9:1至1:1(干重),其在溶于或存在于水中时为pH4时的澄清液体 在10℃下的量为40g / l